For radiation oncologists, the laborious task of determining the treatment plan for cancer patients is being simplified and shortened with the application of AI software from Finnish company MVision.
Drawing up a detailed treatment plan requires consideration of the size and location of the tumor, as well as possible metastases. Physicians define the radiotherapy target by manually delineating structures onto multiple X-ray image slices. There can be hundreds of images, and dozens of critical tissue structures, which makes for a time-consuming error-prone process. MVision's software automatically delineates critical tissue structures for a physician to review and approve.
MVision has now been deployed in two Finnish hospitals, Turku University Hospital (Tyks) and the Docrates Cancer Center in Helsinki, aimed at prostate cancer patients, and will soon accommodate other cancer sites including head and neck cancers, and breast cancer. The company is also now seeking to reach the global market.